271 related articles for article (PubMed ID: 25934693)
1. miR-19-Mediated Inhibition of Transglutaminase-2 Leads to Enhanced Invasion and Metastasis in Colorectal Cancer.
Cellura D; Pickard K; Quaratino S; Parker H; Strefford JC; Thomas GJ; Mitter R; Mirnezami AH; Peake NJ
Mol Cancer Res; 2015 Jul; 13(7):1095-1105. PubMed ID: 25934693
[TBL] [Abstract][Full Text] [Related]
2. Tissue transglutaminase induces Epithelial-Mesenchymal-Transition and the acquisition of stem cell like characteristics in colorectal cancer cells.
Ayinde O; Wang Z; Griffin M
Oncotarget; 2017 Mar; 8(12):20025-20041. PubMed ID: 28223538
[TBL] [Abstract][Full Text] [Related]
3. Transglutaminase 2 Promotes Migration and Invasion of Lung Cancer Cells.
Lee HT; Huang CH; Chen WC; Tsai CS; Chao YL; Liu SH; Chen JH; Wu YY; Lee YJ
Oncol Res; 2018 Sep; 26(8):1175-1182. PubMed ID: 29301592
[TBL] [Abstract][Full Text] [Related]
4. Impact of microRNAs on regulatory networks and pathways in human colorectal carcinogenesis and development of metastasis.
Pizzini S; Bisognin A; Mandruzzato S; Biasiolo M; Facciolli A; Perilli L; Rossi E; Esposito G; Rugge M; Pilati P; Mocellin S; Nitti D; Bortoluzzi S; Zanovello P
BMC Genomics; 2013 Aug; 14():589. PubMed ID: 23987127
[TBL] [Abstract][Full Text] [Related]
5. Transglutaminase Is Required for Epidermal Squamous Cell Carcinoma Stem Cell Survival.
Fisher ML; Keillor JW; Xu W; Eckert RL; Kerr C
Mol Cancer Res; 2015 Jul; 13(7):1083-94. PubMed ID: 25934691
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-499-5p promotes cellular invasion and tumor metastasis in colorectal cancer by targeting FOXO4 and PDCD4.
Liu X; Zhang Z; Sun L; Chai N; Tang S; Jin J; Hu H; Nie Y; Wang X; Wu K; Jin H; Fan D
Carcinogenesis; 2011 Dec; 32(12):1798-805. PubMed ID: 21934092
[TBL] [Abstract][Full Text] [Related]
7. Transglutaminase 2 facilitates the distant hematogenous metastasis of breast cancer by modulating interleukin-6 in cancer cells.
Oh K; Ko E; Kim HS; Park AK; Moon HG; Noh DY; Lee DS
Breast Cancer Res; 2011 Oct; 13(5):R96. PubMed ID: 21967801
[TBL] [Abstract][Full Text] [Related]
8. Pleiotropic actions of miR-21 highlight the critical role of deregulated stromal microRNAs during colorectal cancer progression.
Bullock MD; Pickard KM; Nielsen BS; Sayan AE; Jenei V; Mellone M; Mitter R; Primrose JN; Thomas GJ; Packham GK; Mirnezami AH
Cell Death Dis; 2013 Jun; 4(6):e684. PubMed ID: 23788041
[TBL] [Abstract][Full Text] [Related]
9. MiR-150 alleviates EMT and cell invasion of colorectal cancer through targeting Gli1.
Fan H; Liu X; Zheng WW; Zhuang ZH; Wang CD
Eur Rev Med Pharmacol Sci; 2017 Nov; 21(21):4853-4859. PubMed ID: 29164577
[TBL] [Abstract][Full Text] [Related]
10. Tissue transglutaminase-induced alterations in extracellular matrix inhibit tumor invasion.
Mangala LS; Arun B; Sahin AA; Mehta K
Mol Cancer; 2005 Sep; 4():33. PubMed ID: 16153302
[TBL] [Abstract][Full Text] [Related]
11. A novel extracellular role for tissue transglutaminase in matrix-bound VEGF-mediated angiogenesis.
Wang Z; Perez M; Caja S; Melino G; Johnson TS; Lindfors K; Griffin M
Cell Death Dis; 2013 Sep; 4(9):e808. PubMed ID: 24052076
[TBL] [Abstract][Full Text] [Related]
12. The Role of Transglutaminase 2 in Cancer: An Update.
Zaltron E; Vianello F; Ruzza A; Palazzo A; Brillo V; Celotti I; Scavezzon M; Rossin F; Leanza L; Severin F
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38474044
[TBL] [Abstract][Full Text] [Related]
13. Transglutaminase 2 cross-linking activity is linked to invadopodia formation and cartilage breakdown in arthritis.
Lauzier A; Charbonneau M; Paquette M; Harper K; Dubois CM
Arthritis Res Ther; 2012 Jul; 14(4):R159. PubMed ID: 22762273
[TBL] [Abstract][Full Text] [Related]
14. Tissue transglutaminase-2 promotes gastric cancer progression via the ERK1/2 pathway.
Wang X; Yu Z; Zhou Q; Wu X; Chen X; Li J; Zhu Z; Liu B; Su L
Oncotarget; 2016 Feb; 7(6):7066-79. PubMed ID: 26771235
[TBL] [Abstract][Full Text] [Related]
15. Tumor-suppressive miR-26a and miR-26b inhibit cell aggressiveness by regulating FUT4 in colorectal cancer.
Li Y; Sun Z; Liu B; Shan Y; Zhao L; Jia L
Cell Death Dis; 2017 Jun; 8(6):e2892. PubMed ID: 28640257
[TBL] [Abstract][Full Text] [Related]
16. Transglutaminase 2 overexpression in tumor stroma identifies invasive ductal carcinomas of breast at high risk of recurrence.
Assi J; Srivastava G; Matta A; Chang MC; Walfish PG; Ralhan R
PLoS One; 2013; 8(9):e74437. PubMed ID: 24058567
[TBL] [Abstract][Full Text] [Related]
17. miR-20a targets BNIP2 and contributes chemotherapeutic resistance in colorectal adenocarcinoma SW480 and SW620 cell lines.
Chai H; Liu M; Tian R; Li X; Tang H
Acta Biochim Biophys Sin (Shanghai); 2011 Mar; 43(3):217-25. PubMed ID: 21242194
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA‑214 suppresses the viability, migration and invasion of human colorectal carcinoma cells via targeting transglutaminase 2.
Shan H; Zhou X; Chen C
Mol Med Rep; 2019 Aug; 20(2):1459-1467. PubMed ID: 31173203
[TBL] [Abstract][Full Text] [Related]
19. Effects of Decitabine on Invasion and Exosomal Expression of miR-200c and miR-141 in Oxaliplatin-Resistant Colorectal Cancer Cells.
Tanaka S; Hosokawa M; Ueda K; Iwakawa S
Biol Pharm Bull; 2015; 38(9):1272-9. PubMed ID: 26179333
[TBL] [Abstract][Full Text] [Related]
20. MiR-30a-5p Suppresses Tumor Metastasis of Human Colorectal Cancer by Targeting ITGB3.
Wei W; Yang Y; Cai J; Cui K; Li RX; Wang H; Shang X; Wei D
Cell Physiol Biochem; 2016; 39(3):1165-76. PubMed ID: 27576787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
